Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability

Abstract

BCR/ABL regulates cell proliferation, apoptosis, differentiation and adhesion. In addition, BCR/ABL can induce resistance to cytostatic drugs and irradiation by modulation of DNA repair mechanisms, cell cycle checkpoints and Bcl-2 protein family members. Upon DNA damage BCR/ABL not only enhances reparation of DNA lesions (e.g. homologous recombination repair), but also prolongs activation of cell cycle checkpoints (e.g. G2/M) providing more time for repair of otherwise lethal lesions. Moreover, by modification of anti-apoptotic members of the Bcl-2 family (e.g. upregulation of Bcl-xL) BCR/ABL provides a cytoplasmic ‘umbrella’ protecting mitochondria from the ‘rain’ of apoptotic signals coming from the damaged DNA in the nucleus, thus preventing release of cytochrome c and activation of caspases. The unrepaired and/or aberrantly repaired (but not lethal) DNA lesions resulting from spontaneous and/or drug-induced damage can accumulate in BCR/ABL-transformed cells leading to genomic instability and malignant progression of the disease. Inhibition of BCR/ABL kinase activity by STI571 (Gleevec, imatinib mesylate) reverses drug resistance and, in combination with standard chemotherapeutics can exert strong anti-leukemia effect.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aitken RJ, Krausz C . 2001 Reproduction 122: 497–506

  • Albala JS, Thelen MP, Prange C, Fan W, Christensen M, Thompson LH, Lennon GG . 1997 Genomics 46: 476–479

  • Albrecht T, Schwab R, Henkes M, Peschel C, Huber C, Aulitzky WE . 1996 Br. J. Haematol. 95: 501–507

  • Alimena G, De Cuia MR, Diverio D, Gastaldi R, Nanni M . 1987 Cancer Genet. Cytogenet. 26: 39–50

  • Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR . 1998a Oncogene 16: 1383–1390

  • Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K . 1998b Blood 91: 1700–1705

  • Amos TA, Lewis JL, Grand FH, Gooding RP, Goldman JM, Gordon MY . 1995 Br. J. Haematol. 91: 387–393

  • Antonsson B, Martinou JC . 2000 Exp. Cell Res. 256: 50–57

  • Arnaudeau C, Rozier L, Cazaux C, Defais M, Jenssen D, Helleday T . 2001 Nucleic Acids Res. 29: 662–667

  • Bartek J, Lukas J . 2001 FEBS Lett. 490: 117–122

  • Baumann P, Benson FE, West SC . 1996 Cell 87: 757–766

  • Baumann P, West SC . 1998 Trends Biochem. Sci. 23: 247–251

  • Beck Z, Kiss A, Toth FD, Szabo J, Bacsi A, Balogh E, Borbely A, Telek B, Kovacs E, Olah E, Rak K . 2000 Leuk. Lymphoma 38: 587–597

  • Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ . 1995 Blood 86: 1148–1158

  • Benhar M, Dalyot I, Engelberg D, Levitzki A . 2001 Mol. Cell. Biol. 21: 6913–6926

  • Bishop AJ, Schiestl RH . 2001 Biochim. Biophys. Acta 1471: M109–M121

  • Blasiak J, Gloc E, Mlynarski W, Drzewoski J, Skorski T . 2002 Leuk. Res. 1538: in press

  • Blume-Jensen P, Hunter T . 2001 Nature 411: 355–365

  • Bracey TS, Williams AC, Paraskeva C . 1997 Clin. Cancer Res. 3: 1371–1381

  • Bucka A, Stasiak A . 2001 Nucleic Acids Res. 29: 2464–2470

  • Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG . 1998 Oncogene 16: 335–348

  • Campbell MJ, Davis RW . 1999 J. Mol. Biol. 286: 437–445

  • Canitrot Y, Lautier D, Laurent G, Frechet M, Ahmed A, Turhan AG, Salles B, Cazaux C, Hoffman JS . 1999 Oncogene 18: 2676–2680

  • Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL . 1983 Nature 305: 779–784

  • Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . 1999 Nature 401: 616–620

  • Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B . 2000 Genes Dev. 14: 1584–1588

  • Cherbonnel-Lasserre C, Gauny S, Kronenberg A . 1996 Oncogene 13: 1489–1497

  • Collins MK, Marvel J, Malde P, Lopez-Rivas A . 1992 J. Exp. Med. 176: 1043–1051

  • Collis SJ, Tighe A, Scott SD, Roberts SA, Hendry JH, Margison GP . 2001 Nucleic Acids Res. 29: 1534–1538

  • Coultas L, Strasser A . 2000 Apoptosis 5: 491–507

  • Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY . 1999b Oncogene 18: 7883–7899

  • Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY . 1999a Oncogene 18: 7883–7899

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • de Groot RP, Raaijmakers JA, Lammers JW, Koenderman L . 2000 Mol. Cell. Biol. Res. Commun. 3: 299–305

  • Deutsch E, Dugray A, AbdulKarim B, Marangoni E, Maggiorella L, Vaganay S, M'Kacher R, Rasy SD, Eschwege F, Vainchenker W, Turhan AG, Bourhis J . 2001 Blood 97: 2084–2090

  • DiBiase SJ, Zeng ZC, Chen R, Hyslop T, Curran Jr WJ, Iliakis G . 2000 Cancer Res. 60: 1245–1253

  • Donato NJ, Wu JY, Zhang L, Kantarjian H, Talpaz M . 2001 Blood 97: 2846–2853

  • Dosanjh MK, Collins DW, Fan W, Lennon GG, Albala JS, Shen Z, Schild D . 1998 Nucleic Acids Res. 26: 1179–1184

  • Druker BJ, Sawyers CL, Kantarjian H, Resta D, Reese SF, Ford JM, Capdeville R, Talpaz M . 2001a N. Engl. J. Med. 344: 1038–1042

  • Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . 2001b N. Engl. J. Med. 344: 1031–1037

  • Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E . 1998 Blood 91: 2415–2422

  • Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E . 1995 Leukemia 9: 1013–1024

  • el-Deiry WS . 1997 Curr. Opin. Oncol. 9: 79–87

  • Elledge SJ . 1996 Science 274: 1664–1672

  • Elliott B, Jasin M . 2001 Mol. Cell. Biol. 21: 2671–2682

  • Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J . 2001 Nature 410: 842–847

  • Falkenburg JH, Wafelman AR, Joosten P, Smit WM, van Bergen CA, Bongaerts R, Lurvink E, van der Hoorn M, Kluck P, Landegent JE, Kluin-Nelemans HC, Fibbe WE, Willemze R . 1999 Blood 94: 1201–1208

  • Fang G, Kim CN, Perkins CL, Ramadevi N, Winton E, Wittmann S, Bhalla KN . 2000 Blood 96: 2246–2253

  • Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Bussing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C . 1998 Bone Marrow Transplant. 21: 1029–1036

  • Fishel R . 1999 Nat. Med. 5: 1239–1241

  • Flores-Rozas H, Kolodner RD . 2000 Trends Biochem. Sci. 25: 196–200

  • Fuchs EJ, Bedi A, Jones RJ, Hess AD . 1995 Cancer Res. 55: 463–466

  • Gaiger A, Henn T, Horth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T . 1995 Blood 86: 2371–2378

  • Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm A, Ringden O, Stone JA, Bortin MM . 1994 Ann. Intern. Med. 120: 646–652

  • Gebow D, Miselis N, Liber HL . 2000 Mol. Cell. Biol. 20: 4028–4035

  • Gesbert F, Griffin JD . 2000 Blood 96: 2269–2276

  • Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON . 1995 Cell 82: 981–988

  • Grdina DJ, Kataoka Y, Murley JS . 2000 Drug Metabol. Drug Interact. 16: 237–279

  • Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes Dev. 13: 1899–1911

  • Guinn BA, Smith M, Padua RA, Burnett A, Mills K . 1995 Leuk. Res. 19: 519–525

  • Harrison DJ . 1995 J. Pathol. 175: 7–12

  • Hoeijmakers JH . 2001 Nature 411: 366–374

  • Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa S, Ishikawa T, Yazaki Y, Hirai H . 2000 Blood 95: 1144–1150

  • Hoover RR, Gerlach MJ, Koh EY, Daley GQ . 2001 Oncogene 20: 5826–5835

  • Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, Fernandez-Luna JL . 2000 J. Exp. Med. 191: 977–984

  • Ikawa S, Nakagawara A, Ikawa Y . 1999 Cell Growth Differ. 6: 1154–1161

  • Ilaria Jr RL, Van Etten RA . 1996 J. Biol. Chem. 271: 31704–31710

  • Jakupciak JP, Wells RD . 2000 J. Biol. Chem. 275: 40003–40013

  • Jasin M . 2000 Cancer Invest. 18: 78–86

  • Jeong SJ, Jin YH, Moon CW, Bae HR, Yoo YH, Lee HS, Lee SH, Lim YJ, Lee JD, Jeong MH . 2001 Radiat. Res. 156: 751–760

  • Johnson PA, Clements P, Hudson K, Caldecott KW . 1999 Cancer Res. 59: 2696–2700

  • Jones NJ, Zhao Y, Siciliano MJ, Thompson LH . 1995 Genomics 26: 619–622

  • Kano Y, Akutsu M, Tsunoda S, Mano H, Sato Y, Honma Y, Furukawa Y . 2001 Blood 97: 1999–2007

  • Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A, Rotter V . 1989 Blood 74: 2318–2324

  • Khanna KK, Jackson SP . 2001 Nat. Genet. 27: 247–254

  • Kim C, Rubin CM, Schmid CW . 2001 Gene 276: 127–133

  • Klucher KM, Lopez DV, Daley GQ . 1998 Blood 91: 3927–3934

  • Kohno K, Oshiro T, Kishine H, Wada M, Takeda H, Ihara N, Imamoto F, Kano Y, Schlessinger D . 1997 Gene 188: 175–181

  • Kolibaba KS, Druker BJ . 1997 Biochim. Biophys. Acta 1333: F217–F248

  • Kolodner RD, Marsischky GT . 1999 Curr. Opin. Genet. Dev. 9: 89–96

  • Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA . 2001 Blood 97: 3581–3588

  • Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM . 1994 Microbiol. Rev. 58: 401–465

  • Laneuville P, Sun G, Timm M, Vekemans M . 1992 Blood 80: 1788–1797

  • Laval J . 1996 Pathol. Biol. (Paris) 44: 14–24

  • Li GM . 1999 Oncol. Res. 11: 393–400

  • Li X, Cai M . 1997 Mol. Cell. Biol. 17: 2723–2734

  • Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J . 2000 Science 288: 1425–1429

  • Majsterek I, Blasiak J, Mlynarski W, Hoser G, Skorski T . 2002 Cell Biol. Internatl. 26: 363–370

  • Makin G, Hickman JA . 2000 Cell Tissue Res. 301: 143–152

  • Maru Y, Bergmann E, Coin F, Egly JM, Shibuya M . 2001 Mutat. Res. 483: 83–88

  • Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ, Benson FE, West SC . 2001 Genes Dev. 15: 3296–3307

  • Meyn MS . 1993 Science 260: 1327–1330

  • Michel B, Flores MJ, Viguera E, Grompone G, Seigneur M, Bidnenko V . 2001 Proc. Natl. Acad. Sci. USA 98: 8181–8188

  • Modesti M, Kanaar R . 2001 Curr. Biol. 11: R229–R232

  • Moynahan ME, Chiu JW, Koller BH, Jasin M . 1999 Mol. Cell 4: 511–518

  • Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K . 1992 Cancer Res. 52: 6588–6593

  • Namsaraev E, Berg P . 1997 Mol. Cell. Biol. 17: 5359–5368

  • Neshat MS, Raitano AB, Wang HG, Reed JC, Sawyers CL . 2000 Mol. Cell. Biol. 20: 1179–1186

  • Nieborowska-Skorska M, Nakashima M, Ratajczak M, Steplewski Z, Calabretta B, Skorski T . 1994 Folia. Histochem. Cytobiol. 32: 35–40

  • Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242

  • Nishii K, Kabarowski JH, Gibbons DL, Griffiths SD, Titley I, Wiedemann LM, Greaves MF . 1996 Oncogene 13: 2225–2234

  • Norbury CJ, Hickson ID . 2001 Annu. Rev. Pharmacol. Toxicol. 41: 367–401

  • Papavasiliou FN, Schatz DG . 2000 Nature 408: 216–221

  • Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH . 2000 Cancer Lett. 160: 107–113

  • Pegg AE . 2000 Mutat. Res. 462: 83–100

  • Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ . 1997 Oncogene 15: 537–547

  • Pierce AJ, Hu P, Han M, Ellis N, Jasin M . 2001a Genes Dev. 15: 3237–3242

  • Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M . 2001b Trends Cell Biol. 11: S52–S59

  • Pittman DL, Weinberg LR, Schimenti JC . 1998 Genomics 49: 103–111

  • Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T . 1994 EMBO J. 13: 764–773

  • Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM . 2000 Blood 95: 2913–2921

  • Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T . 2002 Cancer Res. 62: 219–225

  • Richardson C, Jasin M . 2000 Mol. Cell. Biol. 20: 9068–9075

  • Rinehart FP, Ritch TG, Deininger PL, Schmid CW . 1981 Biochemistry 20: 3003–3010

  • Riordan FA, Bravery CA, Mengubas K, Ray N, Borthwick NJ, Akbar AN, Hart SM, Hoffbrand AV, Mehta AB, Wickremasinghe RG . 1998 Oncogene 16: 1533–1542

  • Roger R, Issaad C, Pallardy M, Leglise MC, Turhan AG, Bertoglio J, Breard J . 1996 Blood 87: 1113–1122

  • Rohlfs EM, Chung CH, Yang Q, Skrzynia C, Grody WW, Graham ML, Silverman LM . 2000 Hum. Genet. 107: 385–390

  • Rowley JD, Testa JR . 1982 Adv. Cancer Res. 36: 103–148

  • Salloukh HF, Laneuville P . 2000 Leukemia 14: 1401–1404

  • Salloukh HF, Vowles I, Heisterkamp N, Groffen J, Laneuville P . 2000 Oncogene 19: 4362–4374

  • Salomoni P, Condorelli F, Sweeney SM, Calabretta B . 2000 Blood 96: 676–684

  • Santucci MA, Anklesaria P, Laneuville P, Das IJ, Sakakeeny MA, FitzGerald TJ, Greenberger JS . 1993 Int. J. Radiat. Oncol. Biol. Phys. 26: 831–836

  • Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T, Greenfield EA, Salgia R, Griffin JD . 2000 J. Biol. Chem. 275: 24273–24278

  • Sawyers CL . 1997 Baillieres Clin. Haematol. 10: 223–231

  • Sawyers CL, McLaughlin J, Witte ON . 1995 J. Exp. Med. 181: 307–313

  • Shah JV, Cleveland DW . 2000 Cell 103: 997–1000

  • Shapiro GI, Harper JW . 1999 J. Clin. Invest. 104: 1645–1653

  • Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K, Ogawa T . 1993 Nat. Genet. 4: 239–243

  • Shinohara A, Ogawa H, Ogawa T . 1992 Cell 69: 457–470

  • Shinohara A, Ogawa T . 1995 Trends Biochem. Sci. 20: 387–391

  • Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . 2000 Blood 95: 2118–2125

  • Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B . 1997a EMBO J. 16: 6151–6161

  • Skorski T, Kanakaraj P, Ku DH, Nieborowska-Skorska M, Canaani E, Zon G, Perussia B, Calabretta B . 1994 J. Exp. Med. 179: 1855–1865

  • Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B . 1995 Blood 86: 726–736

  • Skorski T, Nieborowska-Skorska M, Barletta C, Malaguarnera L, Szczylik C, Chen ST, Lange B, Calabretta B . 1993 J. Clin. Invest. 92: 194–202

  • Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B . 1997b J. Natl. Cancer Inst. 89: 124–133

  • Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Martinez R, Wasik MA, Calabretta B . 1996 Proc. Natl. Acad. Sci. USA 93: 13137–13142

  • Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, Skorski T . 2001 Mol. Cell 8: 795–806

  • Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, Fishel R, Skorski T . 2002 Mol. Cell. Biol. 22: 4189–4201

  • Smith GC, Jackson SP . 1999 Genes Dev. 13: 916–934

  • Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchiiwai Y, Takeda S . 1998 EMBO J. 17: 598–608

  • Sonoda E, Sasaki MS, Morrison C, Yamaguchi-Iwai Y, Takata M, Takeda S . 1999 Mol. Cell. Biol. 19: 5166–5169

  • Sonoyama J, Matsumura I, Ezoe S, Satoh Y, Zhang X, Kataoka Y, Takai E, Mizuki M, Machii T, Wakao H, Kanakura Y . 2002 J. Biol. Chem. 4: 4

  • Stuppia L, Calabrese G, Peila R, Guanciali-Franchi P, Morizio E, Spadano A, Palka G . 1997 Cancer Genet. Cytogenet. 98: 28–35

  • Sturzbecher HW, Donzelmann B, Henning W, Knippschild U, Buchhop S . 1996 EMBO J. 15: 1992–2002

  • Takeda NO, Shibuya M, Maru Y . 1999 Proc. Natl. Acad. Sci. USA 96: 203–207

  • Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, Siciliano MJ, Hwang M, Liu N, Legerski RJ, Thompson LH . 1995 Proc. Natl. Acad. Sci. USA 92: 6354–6358

  • Thacker J, Tambini CE, Simpson PJ, Tsui LC, Scherer SW . 1995 Hum. Mol. Genet. 4: 113–120

  • Thiesing JT, Ohno-Jones S, Kolibaba KS, Druker BJ . 2000 Blood 96: 3195–3199

  • Topaly J, Zeller WJ, Fruehauf S . 2001 Leukemia 15: 342–347

  • van der Kuip H, Goetz AW, Miething C, Duyster J, Aulitzky WE . 2001 Blood 98: 1532–1541

  • Vispe S, Cazaux C, Lesca C, Defais M . 1998 Nucleic Acids Res. 26: 2859–2864

  • von Willebrand M, Williams S, Saxena M, Gilman J, Tailor P, Jascur T, Amarante-Mendes GP, Green DR, Mustelin T . 1998 J. Biol. Chem. 273: 3994–4000

  • Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N . 1995 Blood 86: 4603–4611

  • Wang D, Kreutzer DA, Essigmann JM . 1998 Mutat. Res. 400: 99–115

  • Wang H, Zeng ZC, Bui TA, Sonoda E, Takata M, Takeda S, Iliakis G . 2001 Oncogene 20: 2212–2224

  • Wiese C, Pierce AJ, Gauny SS, Jasin M, Kronenberg A . 2002 Cancer Res. 62: 1279–1283

  • Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F, Powell SN . 2000 Oncogene 19: 632–639

  • Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ . 1996 Cell 87: 619–628

  • Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD, Khanna KK . 2000 J. Biol. Chem. 275: 10342–10348

  • Zhou BB, Elledge SJ . 2000 Nature 408: 433–439

Download references

Acknowledgements

This work was supported by grants from NIH/NCI and American Cancer Society. T Skorski is a Scholar of the Leukemia and Lymphoma Society. Special thanks for Michal O Nowicki, whose computer skills were helpful during preparations of the figures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomasz Skorski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skorski, T. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene 21, 8591–8604 (2002). https://doi.org/10.1038/sj.onc.1206087

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206087

Keywords

This article is cited by

Search

Quick links